CAI Q2 2018 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$106M+27.8% YoY

Gross Profit

$52M49.2% margin

Operating Income

$37M35.2% margin

Net Income

$20M19.2% margin

EPS (Diluted)

$1.02

QoQ Revenue Growth

+10.8%

Cash Flow

Operating Cash Flow

$39M

Free Cash Flow

-$120M

Stock-Based Comp.

$746,000

Balance Sheet

Total Assets

$2.7B

Total Liabilities

$2.1B

Stockholders' Equity

$629M

Cash & Equivalents

$41M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$106M	$83M	+27.8%
Gross Profit	$52M	$39M	+33.4%
Operating Income	$37M	$23M	+61.6%
Net Income	$20M	$13M	+60.6%